BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leroux S, Zhao W, Bétrémieux P, Pladys P, Saliba E, Jacqz-Aigrain E; French Society of Neonatology. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child 2015;100:394-8. [PMID: 25628457 DOI: 10.1136/archdischild-2014-306873] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Alsultan A, Alghamdi WA, Alghamdi J, Alharbi AF, Aljutayli A, Albassam A, Almazroo O, Alqahtani S. Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia. Saudi Pharm J 2020;28:1217-27. [PMID: 33132716 DOI: 10.1016/j.jsps.2020.08.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pauwels S, Allegaert K. Therapeutic drug monitoring in neonates. Arch Dis Child 2016;101:377-81. [DOI: 10.1136/archdischild-2013-305309] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
3 Darwich AS, Ogungbenro K, Vinks AA, Powell JR, Reny J, Marsousi N, Daali Y, Fairman D, Cook J, Lesko LJ, Mccune JS, Knibbe CAJ, de Wildt SN, Leeder JS, Neely M, Zuppa AF, Vicini P, Aarons L, Johnson TN, Boiani J, Rostami-hodjegan A. Why Has Model-Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future. Clin Pharmacol Ther 2017;101:646-56. [DOI: 10.1002/cpt.659] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 20.2] [Reference Citation Analysis]
4 Leroux S, Zhao W, Biran V, Jacqz-Aigrain E. [Dosing regimens of antibiotics in neonates: Variations in clinical practice and what should be done?]. Arch Pediatr 2016;23:966-73. [PMID: 27451383 DOI: 10.1016/j.arcped.2016.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Boast A, Gwee A. Absence of evidence: antimicrobial prescribing in neonates, elderly and pregnant women. Intern Med J 2017;47:13-5. [PMID: 28076914 DOI: 10.1111/imj.13310] [Reference Citation Analysis]
6 Leroux S, Roué JM, Gouyon JB, Biran V, Zheng H, Zhao W, Jacqz-Aigrain E. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants. Antimicrob Agents Chemother 2016;60:6626-34. [PMID: 27572399 DOI: 10.1128/AAC.01045-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Leroux S, Elie V, Zhao W, Magreault S, Jacqz-aigrain E. Principles and applications of pharmacometrics in drug evaluation in children. Therapies 2018;73:165-70. [DOI: 10.1016/j.therap.2017.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
8 Smits A, Kulo A, van den Anker J, Allegaert K. The amikacin research program: a stepwise approach to validate dosing regimens in neonates. Expert Opin Drug Metab Toxicol 2017;13:157-66. [PMID: 27623706 DOI: 10.1080/17425255.2017.1234606] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Jacqz-Aigrain E, Leroux S, Thomson AH, Allegaert K, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Nakamura H, van den Anker JN, Sharland M, Zhao W. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. J Antimicrob Chemother 2019;74:2128-38. [PMID: 31049551 DOI: 10.1093/jac/dkz158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
10 Garrido F, Allegaert K, Arribas C, Villamor E, Raffaeli G, Paniagua M, Cavallaro G, On Behalf Of European Antibiotics Study Group Easg. Variations in Antibiotic Use and Sepsis Management in Neonatal Intensive Care Units: A European Survey. Antibiotics (Basel) 2021;10:1046. [PMID: 34572631 DOI: 10.3390/antibiotics10091046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aires J. First 1000 Days of Life: Consequences of Antibiotics on Gut Microbiota. Front Microbiol 2021;12:681427. [PMID: 34093505 DOI: 10.3389/fmicb.2021.681427] [Reference Citation Analysis]
12 Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population. Clin Pharmacokinet 2020;59:501-18. [PMID: 31587145 DOI: 10.1007/s40262-019-00827-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
13 Fleiss N, Hooven TA, Polin RA. Can we back off using antibiotics in the NICU? Semin Fetal Neonatal Med 2021;26:101217. [PMID: 33678550 DOI: 10.1016/j.siny.2021.101217] [Reference Citation Analysis]
14 Hill LF, Turner MA, Lutsar I, Heath PT, Hardy P, Linsell L, Jacqz-Aigrain E, Roilides E, Sharland M; NeoVanc Consortium. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. Trials 2020;21:329. [PMID: 32293527 DOI: 10.1186/s13063-020-4184-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cotten CM. Adverse consequences of neonatal antibiotic exposure. Curr Opin Pediatr 2016;28:141-9. [PMID: 26886785 DOI: 10.1097/MOP.0000000000000338] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 10.2] [Reference Citation Analysis]
16 Litz JE, Goedicke-fritz S, Härtel C, Zemlin M, Simon A. Management of early- and late-onset sepsis: results from a survey in 80 German NICUs. Infection 2019;47:557-64. [DOI: 10.1007/s15010-018-1263-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Shafiq N, Malhotra S, Gautam V, Kaur H, Kumar P, Dutta S, Ray P, Kshirsagar NA. Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates. Indian J Med Res 2017;145:299-316. [PMID: 28749392 DOI: 10.4103/ijmr.IJMR_723_15] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Tang BH, Wu YE, Kou C, Qi YJ, Qi H, Xu HY, Leroux S, Huang X, Zhou Y, Zheng Y, Jacqz-Aigrain E, Shen AD, Zhao W. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants. Antimicrob Agents Chemother 2019;63:e02336-18. [PMID: 30509939 DOI: 10.1128/AAC.02336-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Hawcutt DB, Cooney L, Oni L, Pirmohamed M. Precision Dosing in Children. Expert Review of Precision Medicine and Drug Development 2016;1:69-78. [DOI: 10.1080/23808993.2016.1138845] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Gouyon B, Iacobelli S, Saliba E, Quantin C, Pignolet A, Jacqz-aigrain E, Gouyon JB. A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the ‘preselected prescription’ concept at the bedside. J Clin Pharm Ther 2017;42:64-8. [DOI: 10.1111/jcpt.12474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rodieux F, Wilbaux M, van den Anker JN, Pfister M. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. Clin Pharmacokinet 2015;54:1183-204. [PMID: 26138291 DOI: 10.1007/s40262-015-0298-7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 9.7] [Reference Citation Analysis]
22 Krzyżaniak N, Pawłowska I, Bajorek B. Review of drug utilization patterns in NICUs worldwide. J Clin Pharm Ther 2016;41:612-20. [PMID: 27578606 DOI: 10.1111/jcpt.12440] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
23 Wilbaux M, Fuchs A, Samardzic J, Rodieux F, Csajka C, Allegaert K, van den Anker JN, Pfister M. Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates. J Clin Pharmacol 2016;56:909-35. [PMID: 26766774 DOI: 10.1002/jcph.705] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
24 Girardi A, Galletti S, Raschi E, Koci A, Poluzzi E, Faldella G, De Ponti F. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit. Ital J Pediatr 2017;43:37. [PMID: 28412957 DOI: 10.1186/s13052-017-0354-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
25 Germovsek E, Osborne L, Gunaratnam F, Lounis SA, Busquets FB, Standing JF, Sinha AK. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data. J Antimicrob Chemother 2019;74:1003-11. [PMID: 30668696 DOI: 10.1093/jac/dky525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
26 Jacqz-Aigrain E, Leroux S, Zhao W, van den Anker JN, Sharland M. How to use vancomycin optimally in neonates: remaining questions. Expert Rev Clin Pharmacol 2015;8:635-48. [PMID: 26289222 DOI: 10.1586/17512433.2015.1060124] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
27 Clements MN, Russell N, Bielicki JA, Ellis S, Gastine S, Hsia Y, Standing JF, Walker AS, Sharland M. Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines. PLoS One 2021;16:e0252223. [PMID: 34043696 DOI: 10.1371/journal.pone.0252223] [Reference Citation Analysis]
28 van den Anker J, Allegaert K. Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools. Healthcare (Basel) 2019;7:E28. [PMID: 30781454 DOI: 10.3390/healthcare7010028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
29 Kontou A, Sarafidis K, Roilides E. Antimicrobial dosing in neonates. Expert Rev Clin Pharmacol 2017;10:239-42. [PMID: 28067058 DOI: 10.1080/17512433.2017.1279968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 McMullan B, Cooper C, Spotswood N, James R, Jones C, Konecny P, Blyth C, Karen T. Antibiotic prescribing in neonatal sepsis: an Australian nationwide survey. BMJ Paediatr Open 2020;4:e000643. [PMID: 32232180 DOI: 10.1136/bmjpo-2020-000643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Allegaert K, van den Anker J. Neonates are not just little children and need more finesse in dosing of antibiotics. Acta Clin Belg 2019;74:157-63. [PMID: 29745792 DOI: 10.1080/17843286.2018.1473094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Minotti C, Barbieri E, Giaquinto C, Donà D. Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles. Pathogens 2021;10:1343. [PMID: 34684291 DOI: 10.3390/pathogens10101343] [Reference Citation Analysis]
33 Ge Y, Chipenda Dansokho S, Liao XP. Advanced neonatal medicine in China: Is newborn ward capacity associated with inpatient antibiotic usage? PLoS One 2019;14:e0219630. [PMID: 31408462 DOI: 10.1371/journal.pone.0219630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Aleem S, Wohlfarth M, Cotten CM, Greenberg RG. Infection control and other stewardship strategies in late onset sepsis, necrotizing enterocolitis, and localized infection in the neonatal intensive care unit. Semin Perinatol 2020;44:151326. [PMID: 33158599 DOI: 10.1016/j.semperi.2020.151326] [Reference Citation Analysis]
35 Krekels EHJ, van Hasselt JGC, van den Anker JN, Allegaert K, Tibboel D, Knibbe CAJ. Evidence-based drug treatment for special patient populations through model-based approaches. Eur J Pharm Sci 2017;109S:S22-6. [PMID: 28502674 DOI: 10.1016/j.ejps.2017.05.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
36 Spyridis N, Syridou G, Goossens H, Versporten A, Kopsidas J, Kourlaba G, Bielicki J, Drapier N, Zaoutis T, Tsolia M, Sharland M; ARPEC Project Group Members. Variation in paediatric hospital antibiotic guidelines in Europe. Arch Dis Child 2016;101:72-6. [PMID: 26416900 DOI: 10.1136/archdischild-2015-308255] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
37 Metsvaht T, Nellis G, Varendi H, Nunn AJ, Graham S, Rieutord A, Storme T, McElnay J, Mulla H, Turner MA, Lutsar I. High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatr 2015;15:41. [PMID: 25880733 DOI: 10.1186/s12887-015-0359-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
38 Tu Q, Cotta M, Raman S, Graham N, Schlapbach L, Roberts JA. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations. Expert Rev Clin Pharmacol 2021;:1-17. [PMID: 34313180 DOI: 10.1080/17512433.2021.1961578] [Reference Citation Analysis]
39 Martin-Mons S, Lorrain S, Iacobelli S, Gouyon B, Gouyon JB; B-PEN Study Group. Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards. Front Pharmacol 2020;11:585018. [PMID: 33568992 DOI: 10.3389/fphar.2020.585018] [Reference Citation Analysis]
40 Adams M, Bassler D. Practice variations and rates of late onset sepsis and necrotizing enterocolitis in very preterm born infants, a review. Transl Pediatr 2019;8:212-26. [PMID: 31413955 DOI: 10.21037/tp.2019.07.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Magréault S, Leroux S, Touati J, Storme T, Jacqz-Aigrain E. UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies. J Pharm Biomed Anal 2019;174:256-62. [PMID: 31181488 DOI: 10.1016/j.jpba.2019.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]